Back
In the News

Rosen Quoted on Johnson & Johnson

23 July 2010

People

David L. Rosen

Partner

Washington, D.C. 202.672.5430

Related News

View All Posts
25 July 2024 In the News

Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’

Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024 In the News

Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO

Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024 In the News

Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’

Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”